Neil R. Markel’s practice focuses on public and private merger and acquisition transactions, corporate governance, and shareholder activism.
He also provides advice regarding the fiduciary duties of officers and directors to corporations and their boards, and he regularly represents major investment banking firms acting as financial advisors to acquirors or target companies.
Neil joined the firm in 2007 and became counsel in 2016.
Keysight Technologies in its $1.6 billion acquisition of Ixia.
Consortium of owners, comprised of DTCC, Barclays, Credit Suisse, Goldman Sachs, JPMorgan and State Street, in their sale of Clarient Global to Thomson Reuters.
Warburg Pincus in its acquisition of Ascentium Capital.
Verizon in its acquisition of Fleetmatics.
Higher One in its acquisition by Blackboard.
Samsonite in its acquisition of Tumi.
Triton Container in its all-stock merger with TAL International, and Warburg Pincus and Vestar Capital Partners in their purchase of a controlling interest in Triton Container.
The Home Depot in its $1.6 billion acquisition of Interline Brands.
Warburg Pincus in its acquisition of a majority interest in Sterigenics.
Envision Pharmaceutical Holdings, a portfolio company of TPG, in its sale to Rite Aid Corporation for approximately $2 billion.
Medtronic in its $42.9 billion acquisition of Covidien.
American Express in the formation of a Global Business Travel joint venture with an investment group that includes Qatar Holding, BlackRock, Macquarie and Certares.
The board of directors and special committee of National Financial Partners in the $1.3 billion sale of NFP to affiliates of Madison Dearborn Partners.
Warburg Pincus in its acquisition of Consolidated Precision Products.
XL Capital in its redomestication from the Cayman Islands to Ireland through a Scheme of Arrangement.
“Smoothing the Pathway to Use of Tender Offers in Private Equity Acquisitions,” Harvard Law School Forum on Corporate Governance and Financial Regulation, December 20, 2016
January 29, 2016